HEADER RNA BINDING PROTEIN 17-MAY-10 2XES TITLE HUMAN PATL1 C-TERMINAL DOMAIN (LOOP VARIANT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN PAT1 HOMOLOG 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 517-767; COMPND 5 SYNONYM: PAT1-LIKE PROTEIN 1, PATL1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: HELA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: MODIFIED PRSFDUET-1 KEYWDS MRNA DECAPPING, P-BODIES, RNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.TRITSCHLER,O.WEICHENRIEDER REVDAT 4 23-OCT-24 2XES 1 REMARK LINK REVDAT 3 18-MAY-11 2XES 1 JRNL REMARK REVDAT 2 23-JUN-10 2XES 1 JRNL REVDAT 1 16-JUN-10 2XES 0 JRNL AUTH J.E.BRAUN,F.TRITSCHLER,G.HAAS,C.IGREJA,V.TRUFFAULT, JRNL AUTH 2 O.WEICHENRIEDER,E.IZAURRALDE JRNL TITL THE C-TERMINAL ALPHA-ALPHA SUPERHELIX OF PAT IS REQUIRED FOR JRNL TITL 2 MRNA DECAPPING IN METAZOA. JRNL REF EMBO J. V. 29 2368 2010 JRNL REFN ISSN 0261-4189 JRNL PMID 20543818 JRNL DOI 10.1038/EMBOJ.2010.124 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 32009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1600 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 67.0541 - 4.5240 0.97 3164 164 0.1943 0.1856 REMARK 3 2 4.5240 - 3.5909 0.99 3069 170 0.1690 0.2270 REMARK 3 3 3.5909 - 3.1370 0.99 3039 159 0.1879 0.2335 REMARK 3 4 3.1370 - 2.8502 1.00 3045 145 0.1967 0.2025 REMARK 3 5 2.8502 - 2.6459 1.00 3034 176 0.2096 0.2556 REMARK 3 6 2.6459 - 2.4899 1.00 3051 126 0.2153 0.2919 REMARK 3 7 2.4899 - 2.3652 1.00 3002 178 0.2121 0.2662 REMARK 3 8 2.3652 - 2.2622 1.00 2973 189 0.2143 0.2441 REMARK 3 9 2.2622 - 2.1751 1.00 3050 138 0.2207 0.2720 REMARK 3 10 2.1751 - 2.1000 1.00 2982 155 0.2477 0.2666 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 40.65 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.64230 REMARK 3 B22 (A**2) : 7.28350 REMARK 3 B33 (A**2) : -6.64130 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3917 REMARK 3 ANGLE : 0.930 5291 REMARK 3 CHIRALITY : 0.061 626 REMARK 3 PLANARITY : 0.005 670 REMARK 3 DIHEDRAL : 16.439 1538 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 512-516 AND 703-710 AND 767 OF REMARK 3 CHAIN A ARE DISORDERED. RESIDUES 512-516 AND 704- -708 OF CHAIN REMARK 3 B ARE DISORDERED. REMARK 4 REMARK 4 2XES COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1290043954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9788, 0.9788, 0.97922 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32014 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 67.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10000 REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.66000 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX C/D, AUTOSHARP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG3350, 0.2 M KSCN, PH 7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.32500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.02000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.38000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.02000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.32500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.38000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 664 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 664 TO GLY REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 512 REMARK 465 PRO A 513 REMARK 465 GLN A 514 REMARK 465 ASP A 515 REMARK 465 PRO A 516 REMARK 465 ASP A 703 REMARK 465 PRO A 704 REMARK 465 ALA A 705 REMARK 465 THR A 706 REMARK 465 GLU A 707 REMARK 465 SER A 708 REMARK 465 THR A 709 REMARK 465 GLN A 710 REMARK 465 GLN A 767 REMARK 465 GLY B 512 REMARK 465 PRO B 513 REMARK 465 GLN B 514 REMARK 465 ASP B 515 REMARK 465 PRO B 516 REMARK 465 PRO B 704 REMARK 465 ALA B 705 REMARK 465 THR B 706 REMARK 465 GLU B 707 REMARK 465 SER B 708 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER B 701 7.74 -67.10 REMARK 500 SER B 702 71.08 -158.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2021 DISTANCE = 6.42 ANGSTROMS REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SCN A 1767 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SCN A 1768 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SCN A 1769 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SCN A 1770 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2XEQ RELATED DB: PDB REMARK 900 HUMAN PATL1 C-TERMINAL DOMAIN REMARK 900 RELATED ID: 2XER RELATED DB: PDB REMARK 900 HUMAN PATL1 C-TERMINAL DOMAIN (LOOP VARIANT WITH SULFATES) REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 5 AMINO ACIDS GPQDP RESULT FROM THE 5' CLONING REMARK 999 SITE. RESIDUES 664-673 (QSAATPALSN) HAVE BEEN REPLACED BY REMARK 999 G664 AND S665 DBREF 2XES A 517 767 UNP Q86TB9 PATL1_HUMAN 517 767 DBREF 2XES B 517 767 UNP Q86TB9 PATL1_HUMAN 517 767 SEQADV 2XES GLY A 512 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES PRO A 513 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES GLN A 514 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES ASP A 515 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES PRO A 516 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES GLY A 664 UNP Q86TB9 GLN 664 ENGINEERED MUTATION SEQADV 2XES A UNP Q86TB9 ALA 666 DELETION SEQADV 2XES A UNP Q86TB9 ALA 667 DELETION SEQADV 2XES A UNP Q86TB9 THR 668 DELETION SEQADV 2XES A UNP Q86TB9 PRO 669 DELETION SEQADV 2XES A UNP Q86TB9 ALA 670 DELETION SEQADV 2XES A UNP Q86TB9 LEU 671 DELETION SEQADV 2XES A UNP Q86TB9 SER 672 DELETION SEQADV 2XES A UNP Q86TB9 ASN 673 DELETION SEQADV 2XES GLY B 512 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES PRO B 513 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES GLN B 514 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES ASP B 515 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES PRO B 516 UNP Q86TB9 EXPRESSION TAG SEQADV 2XES GLY B 664 UNP Q86TB9 GLN 664 ENGINEERED MUTATION SEQADV 2XES B UNP Q86TB9 ALA 666 DELETION SEQADV 2XES B UNP Q86TB9 ALA 667 DELETION SEQADV 2XES B UNP Q86TB9 THR 668 DELETION SEQADV 2XES B UNP Q86TB9 PRO 669 DELETION SEQADV 2XES B UNP Q86TB9 ALA 670 DELETION SEQADV 2XES B UNP Q86TB9 LEU 671 DELETION SEQADV 2XES B UNP Q86TB9 SER 672 DELETION SEQADV 2XES B UNP Q86TB9 ASN 673 DELETION SEQRES 1 A 248 GLY PRO GLN ASP PRO ASP LYS ARG ARG LYS THR LEU VAL SEQRES 2 A 248 ILE ILE GLU LYS THR TYR SER LEU LEU LEU ASP VAL GLU SEQRES 3 A 248 ASP TYR GLU ARG ARG TYR LEU LEU SER LEU GLU GLU GLU SEQRES 4 A 248 ARG PRO ALA LEU MSE ASP ASP ARG LYS HIS LYS ILE CYS SEQRES 5 A 248 SER MSE TYR ASP ASN LEU ARG GLY LYS LEU PRO GLY GLN SEQRES 6 A 248 GLU ARG PRO SER ASP ASP HIS PHE VAL GLN ILE MSE CYS SEQRES 7 A 248 ILE ARG LYS GLY LYS ARG MSE VAL ALA ARG ILE LEU PRO SEQRES 8 A 248 PHE LEU SER THR GLU GLN ALA ALA ASP ILE LEU MSE THR SEQRES 9 A 248 THR ALA ARG ASN LEU PRO PHE LEU ILE LYS LYS ASP ALA SEQRES 10 A 248 GLN ASP GLU VAL LEU PRO CYS LEU LEU SER PRO PHE SER SEQRES 11 A 248 LEU LEU LEU TYR HIS LEU PRO SER VAL SER ILE THR SER SEQRES 12 A 248 LEU LEU ARG GLN LEU MSE ASN LEU PRO GLY SER PRO HIS SEQRES 13 A 248 LEU THR ALA VAL LEU GLN ASN LYS PHE GLY LEU SER LEU SEQRES 14 A 248 LEU LEU ILE LEU LEU SER ARG GLY GLU ASP LEU GLN SER SEQRES 15 A 248 SER ASP PRO ALA THR GLU SER THR GLN ASN ASN GLN TRP SEQRES 16 A 248 THR GLU VAL MSE PHE MSE ALA THR ARG GLU LEU LEU ARG SEQRES 17 A 248 ILE PRO GLN ALA ALA LEU ALA LYS PRO ILE SER ILE PRO SEQRES 18 A 248 THR ASN LEU VAL SER LEU PHE SER ARG TYR VAL ASP ARG SEQRES 19 A 248 GLN LYS LEU ASN LEU LEU GLU THR LYS LEU GLN LEU VAL SEQRES 20 A 248 GLN SEQRES 1 B 248 GLY PRO GLN ASP PRO ASP LYS ARG ARG LYS THR LEU VAL SEQRES 2 B 248 ILE ILE GLU LYS THR TYR SER LEU LEU LEU ASP VAL GLU SEQRES 3 B 248 ASP TYR GLU ARG ARG TYR LEU LEU SER LEU GLU GLU GLU SEQRES 4 B 248 ARG PRO ALA LEU MSE ASP ASP ARG LYS HIS LYS ILE CYS SEQRES 5 B 248 SER MSE TYR ASP ASN LEU ARG GLY LYS LEU PRO GLY GLN SEQRES 6 B 248 GLU ARG PRO SER ASP ASP HIS PHE VAL GLN ILE MSE CYS SEQRES 7 B 248 ILE ARG LYS GLY LYS ARG MSE VAL ALA ARG ILE LEU PRO SEQRES 8 B 248 PHE LEU SER THR GLU GLN ALA ALA ASP ILE LEU MSE THR SEQRES 9 B 248 THR ALA ARG ASN LEU PRO PHE LEU ILE LYS LYS ASP ALA SEQRES 10 B 248 GLN ASP GLU VAL LEU PRO CYS LEU LEU SER PRO PHE SER SEQRES 11 B 248 LEU LEU LEU TYR HIS LEU PRO SER VAL SER ILE THR SER SEQRES 12 B 248 LEU LEU ARG GLN LEU MSE ASN LEU PRO GLY SER PRO HIS SEQRES 13 B 248 LEU THR ALA VAL LEU GLN ASN LYS PHE GLY LEU SER LEU SEQRES 14 B 248 LEU LEU ILE LEU LEU SER ARG GLY GLU ASP LEU GLN SER SEQRES 15 B 248 SER ASP PRO ALA THR GLU SER THR GLN ASN ASN GLN TRP SEQRES 16 B 248 THR GLU VAL MSE PHE MSE ALA THR ARG GLU LEU LEU ARG SEQRES 17 B 248 ILE PRO GLN ALA ALA LEU ALA LYS PRO ILE SER ILE PRO SEQRES 18 B 248 THR ASN LEU VAL SER LEU PHE SER ARG TYR VAL ASP ARG SEQRES 19 B 248 GLN LYS LEU ASN LEU LEU GLU THR LYS LEU GLN LEU VAL SEQRES 20 B 248 GLN MODRES 2XES MSE A 555 MET SELENOMETHIONINE MODRES 2XES MSE A 565 MET SELENOMETHIONINE MODRES 2XES MSE A 588 MET SELENOMETHIONINE MODRES 2XES MSE A 596 MET SELENOMETHIONINE MODRES 2XES MSE A 614 MET SELENOMETHIONINE MODRES 2XES MSE A 660 MET SELENOMETHIONINE MODRES 2XES MSE A 718 MET SELENOMETHIONINE MODRES 2XES MSE A 720 MET SELENOMETHIONINE MODRES 2XES MSE B 555 MET SELENOMETHIONINE MODRES 2XES MSE B 565 MET SELENOMETHIONINE MODRES 2XES MSE B 588 MET SELENOMETHIONINE MODRES 2XES MSE B 596 MET SELENOMETHIONINE MODRES 2XES MSE B 614 MET SELENOMETHIONINE MODRES 2XES MSE B 660 MET SELENOMETHIONINE MODRES 2XES MSE B 718 MET SELENOMETHIONINE MODRES 2XES MSE B 720 MET SELENOMETHIONINE HET MSE A 555 8 HET MSE A 565 8 HET MSE A 588 8 HET MSE A 596 8 HET MSE A 614 8 HET MSE A 660 8 HET MSE A 718 8 HET MSE A 720 8 HET MSE B 555 8 HET MSE B 565 8 HET MSE B 588 8 HET MSE B 596 8 HET MSE B 614 8 HET MSE B 660 8 HET MSE B 718 8 HET MSE B 720 8 HET SCN A1767 3 HET SCN A1768 3 HET SCN A1769 3 HET SCN A1770 3 HET K A1771 1 HET K B1767 1 HETNAM MSE SELENOMETHIONINE HETNAM SCN THIOCYANATE ION HETNAM K POTASSIUM ION FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 3 SCN 4(C N S 1-) FORMUL 7 K 2(K 1+) FORMUL 9 HOH *519(H2 O) HELIX 1 1 LYS A 518 LEU A 544 1 27 HELIX 2 2 ARG A 551 ARG A 570 1 20 HELIX 3 3 ASP A 582 MSE A 588 1 7 HELIX 4 4 ARG A 591 ILE A 600 1 10 HELIX 5 5 THR A 606 ARG A 618 1 13 HELIX 6 6 LEU A 620 LYS A 626 1 7 HELIX 7 7 LEU A 637 LEU A 644 1 8 HELIX 8 8 SER A 649 LEU A 659 1 11 HELIX 9 9 THR A 677 LEU A 680 1 4 HELIX 10 10 LYS A 683 GLN A 700 1 18 HELIX 11 11 ASN A 712 ARG A 727 1 16 HELIX 12 12 LEU A 743 TYR A 750 1 8 HELIX 13 13 ARG A 753 LYS A 762 1 10 HELIX 14 14 LYS B 518 GLU B 537 1 20 HELIX 15 15 TYR B 539 LEU B 544 1 6 HELIX 16 16 ARG B 551 ARG B 570 1 20 HELIX 17 17 ASP B 582 ILE B 587 1 6 HELIX 18 18 ARG B 591 ILE B 600 1 10 HELIX 19 19 THR B 606 ARG B 618 1 13 HELIX 20 20 LEU B 620 LYS B 626 1 7 HELIX 21 21 LEU B 637 LEU B 644 1 8 HELIX 22 22 SER B 649 GLN B 658 1 10 HELIX 23 23 HIS B 675 LEU B 680 1 6 HELIX 24 24 LYS B 683 GLN B 700 1 18 HELIX 25 25 GLN B 710 ARG B 727 1 18 HELIX 26 26 LEU B 743 SER B 748 1 6 HELIX 27 27 ARG B 753 LEU B 763 1 11 LINK C LEU A 554 N MSE A 555 1555 1555 1.33 LINK C MSE A 555 N ASP A 556 1555 1555 1.33 LINK C SER A 564 N MSE A 565 1555 1555 1.33 LINK C MSE A 565 N TYR A 566 1555 1555 1.32 LINK C ILE A 587 N MSE A 588 1555 1555 1.33 LINK C MSE A 588 N CYS A 589 1555 1555 1.33 LINK C ARG A 595 N MSE A 596 1555 1555 1.33 LINK C MSE A 596 N VAL A 597 1555 1555 1.33 LINK C LEU A 613 N MSE A 614 1555 1555 1.33 LINK C MSE A 614 N THR A 615 1555 1555 1.33 LINK C LEU A 659 N MSE A 660 1555 1555 1.33 LINK C MSE A 660 N ASN A 661 1555 1555 1.33 LINK C VAL A 717 N MSE A 718 1555 1555 1.33 LINK C MSE A 718 N PHE A 719 1555 1555 1.33 LINK C PHE A 719 N MSE A 720 1555 1555 1.33 LINK C MSE A 720 N ALA A 721 1555 1555 1.33 LINK C LEU B 554 N MSE B 555 1555 1555 1.33 LINK C MSE B 555 N ASP B 556 1555 1555 1.33 LINK C SER B 564 N MSE B 565 1555 1555 1.33 LINK C MSE B 565 N TYR B 566 1555 1555 1.33 LINK C ILE B 587 N MSE B 588 1555 1555 1.33 LINK C MSE B 588 N CYS B 589 1555 1555 1.33 LINK C ARG B 595 N MSE B 596 1555 1555 1.34 LINK C MSE B 596 N VAL B 597 1555 1555 1.33 LINK C LEU B 613 N MSE B 614 1555 1555 1.33 LINK C MSE B 614 N THR B 615 1555 1555 1.33 LINK C LEU B 659 N MSE B 660 1555 1555 1.33 LINK C MSE B 660 N ASN B 661 1555 1555 1.33 LINK C VAL B 717 N MSE B 718 1555 1555 1.33 LINK C MSE B 718 N PHE B 719 1555 1555 1.33 LINK C PHE B 719 N MSE B 720 1555 1555 1.33 LINK C MSE B 720 N ALA B 721 1555 1555 1.33 CISPEP 1 SER A 665 PRO A 674 0 5.64 SITE 1 AC1 4 ALA A 610 SER A 651 TYR B 543 ARG B 551 SITE 1 AC2 2 ARG A 599 HOH A2243 SITE 1 AC3 4 PHE A 622 LYS A 625 THR B 677 ARG B 727 SITE 1 AC4 3 HOH A2244 LYS B 592 ARG B 599 CRYST1 56.650 70.760 134.040 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017652 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014132 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007460 0.00000